The JDRF T1D Fund is a venture philanthropy fund that makes catalytic equity investments in early-stage companies focused on developing cures, preventions, and improved treatments for type 1 diabetes (T1D). Its strategy involves reinvesting any financial gains back into the fund to accelerate further research and development in the T1D field.
100% of their portfolio is in Biotech & Life Sciences. Their most common stage is series-c (100% of deals).
Portfolio
1
Fund Size
$100M
Top Stage
Series C
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Portfolio
1 investment
| Company | Round | Amount | Date |
|---|---|---|---|
 SQZ Biotechnologies | Series C | $72M | Aug 2018 |
Top Co-Investors
Everblue1 shared
Illumina Ventures1 shared
Invus1 shared
GV (Google Ventures)1 shared
NanoDimension1 shared
Polaris Venture Partners1 shared
Last updated: 4 May 2026